Ana Flávia Marques Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Flávia Marques Pereira has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Vera Lúcia Mores Rall
Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University, Botucatu, SP, 18618-691, Brazil
5 shared publications - Ary Fernandes Júnior
Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University, Botucatu 18618-691, Brazil
4 shared publications - Alessandra Aguirra Sani
Júlio de Mesquita Filho State University of São Paulo (UNESP), Brazil
3 shared publications Ary Fernandes Júnior
Department of Microbiology and Immunology, São Paulo State University, 18618-691, Brazil
3 shared publicationsBruna Fernanda Murbach Teles Andrade
Department of Microbiology and Immunology, São Paulo State University, 18618-691, Brazil
3 shared publicationsFernanda Cristina Bérgamo Alves
Department of Microbiology and Immunology, São Paulo State University, 18618-691, Brazil
3 shared publications
Latest Publications
- Open Access
Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins
Currently, commercially available pain medications can cause adverse effects. Within this framework, researchers have been exploring new drug candidates derived from animal venoms and toxins. The objective of this study was to investigate the number of molecules with potential for pain relief derived from animal venoms and toxins, which could potentially contribute to the development of new biopharmaceuticals. We conducted a literature search in January 2025, covering the period from 1960 to 2025, in two Latin American and nine international scientific databases. The results consisted of 212 articles selected for review. From these articles, 152 toxins and venoms with analgesic potential were identified and classified into 14 different types of pharmacological targets. The peptides investigated, with masses between 500 Da and 5000 Da, are strong candidates for alternative biopharmaceuticals. Most of the toxins found interact with ion channels, representing an alternative to commercially available drugs.
Open AccessExploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins
Currently, commercially available pain medications can cause adverse effects. Within this framework, researchers have been exploring new drug candidates derived from animal venoms and toxins. The objective of this study was to investigate the number of molecules with potential for pain relief derived from animal venoms and toxins, which could potentially contribute to the development of new biopharmaceuticals. We conducted a literature search in January 2025, covering the period from 1960 to 2025, in two Latin American and nine international scientific databases. The results consisted of 212 articles selected for review. From these articles, 152 toxins and venoms with analgesic potential were identified and classified into 14 different types of pharmacological targets. The peptides investigated, with masses between 500 Da and 5000 Da, are strong candidates for alternative biopharmaceuticals. Most of the toxins found interact with ion channels, representing an alternative to commercially available drugs.
- Open Access
- 23 July 2025
- Published by Revista Veterinaria e Zootecnia in Veterinária e Zootecnia
- Vol. 32, 1-11
ANTIBACTERIAL POTENTIAL OF ESSENTIAL OILS FROM MELALEUCA ALTERNIFOLIA, MENTHA PIPERITA, AND ROSMARINUS OFFICINALIS AGAINST STAPHYLOCOCCUS PSEUDINTERMEDIUS ISOLATES
Staphylococcus pseudintermedius is the main opportunistic agent related to canine pyoderma, composing the natural microbiota of hair follicles. It is considered the main cause of the use of antibiotics in small animals. Reports of methicillin-resistant S. pseudintermedius (MRSP) have become frequent in the veterinary clinical routine of small animals. Essential oils (EOs) have been studied and become a therapeutic alternative. The in vitro antibacterial activity of Melaleuca alternifolia, Mentha piperita, and Rosmarinus officinalis EOs against MRSP isolates and methicillin-susceptible S. pseudintermedius (MSSP) was evaluated. Assays were performed using the broth microdilution assay aiming for minimum inhibitory concentrations (MIC). Different concentrations of the EOs were placed (31.25 to 64000 μg/ml). The MIC values of the EOs from M. alternifolia, M. piperita, and R. officinalis against MRSP isolate were 10667, 32000, and 42666 μg/ml, respectively. M. piperita (EOMP) showed the lowest MIC value (5333 μg/ml) and EOMA from M. alternifolia showed the highest MIC value (37333 μg/ml) against MSSP. Therefore, the antibacterial effectiveness of the EOs can be considered for further therapeutic use.
- 23 July 2025
- Published by Revista Veterinaria e Zootecnia in Veterinária e Zootecnia
- Vol. 32, 1-11
Open AccessANTIBACTERIAL POTENTIAL OF ESSENTIAL OILS FROM MELALEUCA ALTERNIFOLIA, MENTHA PIPERITA, AND ROSMARINUS OFFICINALIS AGAINST STAPHYLOCOCCUS PSEUDINTERMEDIUS ISOLATES
Staphylococcus pseudintermedius is the main opportunistic agent related to canine pyoderma, composing the natural microbiota of hair follicles. It is considered the main cause of the use of antibiotics in small animals. Reports of methicillin-resistant S. pseudintermedius (MRSP) have become frequent in the veterinary clinical routine of small animals. Essential oils (EOs) have been studied and become a therapeutic alternative. The in vitro antibacterial activity of Melaleuca alternifolia, Mentha piperita, and Rosmarinus officinalis EOs against MRSP isolates and methicillin-susceptible S. pseudintermedius (MSSP) was evaluated. Assays were performed using the broth microdilution assay aiming for minimum inhibitory concentrations (MIC). Different concentrations of the EOs were placed (31.25 to 64000 μg/ml). The MIC values of the EOs from M. alternifolia, M. piperita, and R. officinalis against MRSP isolate were 10667, 32000, and 42666 μg/ml, respectively. M. piperita (EOMP) showed the lowest MIC value (5333 μg/ml) and EOMA from M. alternifolia showed the highest MIC value (37333 μg/ml) against MSSP. Therefore, the antibacterial effectiveness of the EOs can be considered for further therapeutic use.
- Open Access
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Investigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.
- 8 July 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1610
Open AccessInvestigating the Antimicrobial Activity of Anuran Toxins
Anurans, commonly known as frogs and toads, comprise a diverse group of amphibians distributed across all continents except Antarctica. This manuscript provides a detailed overview of the global anuran fauna, emphasizing their biology, remarkable adaptations, and ecological importance. A particular focus is placed on their specialized cutaneous glands, which are crucial for defense, communication, and survival. These glands secrete a diverse array of bioactive compounds, including peptides, alkaloids, and other secondary metabolites, shaped by evolutionary pressures. Among these compounds, toxins with potent antimicrobial properties stand out due to their ability to combat a broad spectrum of microbial pathogens. We explore the chemical diversity of these secretions, analyzing their modes of action and their potential applications in combating antibiotic-resistant bacteria and other pathogens. By integrating knowledge, this study underscores the importance of anurans as both ecological keystones and a valuable resource for biotechnological innovations. Furthermore, it highlights the urgent need to conserve anuran biodiversity for harnessing their potential in the development of novel antimicrobial agents to address global health challenges.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 61, e24143
Plantago major leaf extract against bacteria and fungi of medical importance
Antimicrobial drug resistance is a challenge to public health. Various microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, carbapenemase-producing Klebsiella pneumoniae, Pythium insidiosum, and Candida auris, have developed resistance to commonly used antimicrobials in infection disease treatments. Consequently, there is an urgent need to explore and develop novel therapeutic drugs. Natural products, particularly medicinal plants, have received attention in the quest for innovative treatments for various diseases. Plantago major is a plant endowed with several biological properties, such as antibacterial, antifungal, and healing actions. This study aimed to investigate the antimicrobial activities of the methanolic extract obtained from the leaves of P. major. Microdilution assays were conducted to determine the minimum inhibitory concentration and minimum bactericidal and fungicidal concentration. Additionally, synergism with antimicrobial drugs was assessed using a time-kill curve analysis. A synergistic bactericidal interaction between the extract and imipenem was observed against carbapenemase-producing K. pneumoniae. For MRSA, a bacteriostatic synergism was noted in combinations of the extract with cephalotin and oxacillin. For C. auris, a fungistatic interaction was observed between the extract and amphotericin B. These results suggest the presence of bioactive compounds within the extract with therapeutic potential for combating infections caused by these microorganisms.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 61, e24143
Open AccessPlantago major leaf extract against bacteria and fungi of medical importance
Antimicrobial drug resistance is a challenge to public health. Various microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, carbapenemase-producing Klebsiella pneumoniae, Pythium insidiosum, and Candida auris, have developed resistance to commonly used antimicrobials in infection disease treatments. Consequently, there is an urgent need to explore and develop novel therapeutic drugs. Natural products, particularly medicinal plants, have received attention in the quest for innovative treatments for various diseases. Plantago major is a plant endowed with several biological properties, such as antibacterial, antifungal, and healing actions. This study aimed to investigate the antimicrobial activities of the methanolic extract obtained from the leaves of P. major. Microdilution assays were conducted to determine the minimum inhibitory concentration and minimum bactericidal and fungicidal concentration. Additionally, synergism with antimicrobial drugs was assessed using a time-kill curve analysis. A synergistic bactericidal interaction between the extract and imipenem was observed against carbapenemase-producing K. pneumoniae. For MRSA, a bacteriostatic synergism was noted in combinations of the extract with cephalotin and oxacillin. For C. auris, a fungistatic interaction was observed between the extract and amphotericin B. These results suggest the presence of bioactive compounds within the extract with therapeutic potential for combating infections caused by these microorganisms.
- Open Access
- 10 January 2024
- Published by Qeios Ltd
Review of: "In-Vitro Antibacterial Activity of some Ganoderma Species: A Review"
The abstract requires improvement, particularly with regard to providing more information about Ganoderma. I suggest initiating the manuscript with a detailed description of Ganoderma, rather than focusing on the Diabetic Foot Ulcer, as it is not the...
- 10 January 2024
- Published by Qeios Ltd
Open AccessReview of: "In-Vitro Antibacterial Activity of some Ganoderma Species: A Review"
The abstract requires improvement, particularly with regard to providing more information about Ganoderma. I suggest initiating the manuscript with a detailed description of Ganoderma, rather than focusing on the Diabetic Foot Ulcer, as it is not the...
- Open Access
- 13 December 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (12) , 2766
Unveiling the Pain Relief Potential: Harnessing Analgesic Peptides from Animal Venoms
The concept of pain encompasses a complex interplay of sensory and emotional experiences associated with actual or potential tissue damage. Accurately describing and localizing pain, whether acute or chronic, mild or severe, poses a challenge due to its diverse manifestations. Understanding the underlying origins and mechanisms of these pain variations is crucial for effective management and pharmacological interventions. Derived from a wide spectrum of species, including snakes, arthropods, mollusks, and vertebrates, animal venoms have emerged as abundant repositories of potential biomolecules exhibiting analgesic properties across a broad spectrum of pain models. This review focuses on highlighting the most promising venom-derived toxins investigated as potential prototypes for analgesic drugs. The discussion further encompasses research prospects, challenges in advancing analgesics, and the practical application of venom-derived toxins. As the field continues its evolution, tapping into the latent potential of these natural bioactive compounds holds the key to pioneering approaches in pain management and treatment. Therefore, animal toxins present countless possibilities for treating pain caused by different diseases. The development of new analgesic drugs from toxins is one of the directions that therapy must follow, and it seems to be moving forward by recommending the composition of multimodal therapy to combat pain.
- 13 December 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (12) , 2766
Open AccessUnveiling the Pain Relief Potential: Harnessing Analgesic Peptides from Animal Venoms
The concept of pain encompasses a complex interplay of sensory and emotional experiences associated with actual or potential tissue damage. Accurately describing and localizing pain, whether acute or chronic, mild or severe, poses a challenge due to its diverse manifestations. Understanding the underlying origins and mechanisms of these pain variations is crucial for effective management and pharmacological interventions. Derived from a wide spectrum of species, including snakes, arthropods, mollusks, and vertebrates, animal venoms have emerged as abundant repositories of potential biomolecules exhibiting analgesic properties across a broad spectrum of pain models. This review focuses on highlighting the most promising venom-derived toxins investigated as potential prototypes for analgesic drugs. The discussion further encompasses research prospects, challenges in advancing analgesics, and the practical application of venom-derived toxins. As the field continues its evolution, tapping into the latent potential of these natural bioactive compounds holds the key to pioneering approaches in pain management and treatment. Therefore, animal toxins present countless possibilities for treating pain caused by different diseases. The development of new analgesic drugs from toxins is one of the directions that therapy must follow, and it seems to be moving forward by recommending the composition of multimodal therapy to combat pain.
- Open Access
- 27 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (12) , 2868
Synergistic Antibacterial Efficacy of Melittin in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus aureus (MRSA) often cause infections with high mortality rates. Antimicrobial peptides are a source of molecules for developing antimicrobials; one such peptide is melittin, a fraction from the venom of the Apis mellifera bee. This study aimed to evaluate the antibacterial and antibiofilm activities of melittin and its association with oxacillin (mel+oxa) against MRSA isolates, and to investigate the mechanisms of action of the treatments on MRSA. Minimum inhibitory concentrations (MICs) were determined, and synergistic effects of melittin with oxacillin and cephalothin were assessed. Antibiofilm and cytotoxic activities, as well as their impact on the cell membrane, were evaluated for melittin, oxacillin, and mel+oxa. Proteomics evaluated the effects of the treatments on MRSA. Melittin mean MICs for MRSA was 4.7 μg/mL and 12 μg/mL for oxacillin. Mel+oxa exhibited synergistic effects, reducing biofilm formation, and causing leakage of proteins, nucleic acids, potassium, and phosphate ions, indicating action on cell membrane. Melittin and mel+oxa, at MIC values, did not induce hemolysis and apoptosis in HaCaT cells. The treatments resulted in differential expression of proteins associated with protein synthesis and energy metabolism. Mel+oxa demonstrated antibacterial activity against MRSA, suggesting a potential as a candidate for the development of new antibacterial agents against MRSA.
- 27 November 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (12) , 2868
Open AccessSynergistic Antibacterial Efficacy of Melittin in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA)
Methicillin-resistant Staphylococcus aureus (MRSA) often cause infections with high mortality rates. Antimicrobial peptides are a source of molecules for developing antimicrobials; one such peptide is melittin, a fraction from the venom of the Apis mellifera bee. This study aimed to evaluate the antibacterial and antibiofilm activities of melittin and its association with oxacillin (mel+oxa) against MRSA isolates, and to investigate the mechanisms of action of the treatments on MRSA. Minimum inhibitory concentrations (MICs) were determined, and synergistic effects of melittin with oxacillin and cephalothin were assessed. Antibiofilm and cytotoxic activities, as well as their impact on the cell membrane, were evaluated for melittin, oxacillin, and mel+oxa. Proteomics evaluated the effects of the treatments on MRSA. Melittin mean MICs for MRSA was 4.7 μg/mL and 12 μg/mL for oxacillin. Mel+oxa exhibited synergistic effects, reducing biofilm formation, and causing leakage of proteins, nucleic acids, potassium, and phosphate ions, indicating action on cell membrane. Melittin and mel+oxa, at MIC values, did not induce hemolysis and apoptosis in HaCaT cells. The treatments resulted in differential expression of proteins associated with protein synthesis and energy metabolism. Mel+oxa demonstrated antibacterial activity against MRSA, suggesting a potential as a candidate for the development of new antibacterial agents against MRSA.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 28, 20220025
Inhibitory activities of propolis, nisin, melittin and essential oil compounds on Paenibacillus alvei and Bacillus subtilis
Natural products represent important sources of antimicrobial compounds. Propolis and compounds from essential oils comprise good examples of such substances because of their inhibitory effects on bacterial spores, including bee pathogens. Ethanol extracts of propolis (EEP) from Apis mellifera were prepared using different methods: double ultrasonication, double maceration and maceration associated with ultrasonication. Together with the antimicrobial peptides nisin and melittin, and compounds present in the essential oils of clove (Syzygium aromaticum) and cinnamon (Cinnamomum zeylanicum), assays were carried out on one Bacillus subtilis isolate and Paenibacillus alvei (ATCC 6344) against vegetative and sporulated forms, using the resazurin microtiter assay. Synergism with all the antimicrobials in association with tetracycline was verified by the time-kill curve method. Potassium and phosphate efflux, release of proteins and nucleic acids were investigated. EEPs showed the same MIC, 156.25 µg/mL against B. subtilis and 78.12 µg/mL against P. alvei. The peptides showed better activities against B. subtilis (MIC of 12 µg/mL for melittin and 37.50 µg/mL for nisin). Antimicrobials showed similar inhibitory effects, but cinnamaldehyde (39.06 µg/mL) showed the best action against P. alvei. Melittin and nisin showed the greatest capacity to reduce spores, regarding B. subtilis there was a 100% reduction at 6.25 and 0.78 µg/mL, respectively. Concerning P. alvei, the reduction was 93 and 98% at concentrations of 80 µg/mL of melittin and 15 µg/mL of nisin. EEPs showed the highest effects on the protein release against B. subtilis and P. alvei. Nucleic acid release, phosphate and potassium efflux assays indicated bacterial cell membrane damage. Synergism between antimicrobials and tetracycline was demonstrated against both bacteria. All antimicrobials tested showed antibacterial activities against vegetative and sporulated forms of P. alvei and B. subtilis, especially nisin and melittin. Synergism with tetracycline and damage on bacterial cell membrane also occurred.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 28, 20220025
Open AccessInhibitory activities of propolis, nisin, melittin and essential oil compounds on Paenibacillus alvei and Bacillus subtilis
Natural products represent important sources of antimicrobial compounds. Propolis and compounds from essential oils comprise good examples of such substances because of their inhibitory effects on bacterial spores, including bee pathogens. Ethanol extracts of propolis (EEP) from Apis mellifera were prepared using different methods: double ultrasonication, double maceration and maceration associated with ultrasonication. Together with the antimicrobial peptides nisin and melittin, and compounds present in the essential oils of clove (Syzygium aromaticum) and cinnamon (Cinnamomum zeylanicum), assays were carried out on one Bacillus subtilis isolate and Paenibacillus alvei (ATCC 6344) against vegetative and sporulated forms, using the resazurin microtiter assay. Synergism with all the antimicrobials in association with tetracycline was verified by the time-kill curve method. Potassium and phosphate efflux, release of proteins and nucleic acids were investigated. EEPs showed the same MIC, 156.25 µg/mL against B. subtilis and 78.12 µg/mL against P. alvei. The peptides showed better activities against B. subtilis (MIC of 12 µg/mL for melittin and 37.50 µg/mL for nisin). Antimicrobials showed similar inhibitory effects, but cinnamaldehyde (39.06 µg/mL) showed the best action against P. alvei. Melittin and nisin showed the greatest capacity to reduce spores, regarding B. subtilis there was a 100% reduction at 6.25 and 0.78 µg/mL, respectively. Concerning P. alvei, the reduction was 93 and 98% at concentrations of 80 µg/mL of melittin and 15 µg/mL of nisin. EEPs showed the highest effects on the protein release against B. subtilis and P. alvei. Nucleic acid release, phosphate and potassium efflux assays indicated bacterial cell membrane damage. Synergism between antimicrobials and tetracycline was demonstrated against both bacteria. All antimicrobials tested showed antibacterial activities against vegetative and sporulated forms of P. alvei and B. subtilis, especially nisin and melittin. Synergism with tetracycline and damage on bacterial cell membrane also occurred.
- 1 April 2020
- Published by Elsevier in Microbial Pathogenesis
- Vol. 141, 104011
Influence of apitoxin and melittin from Apis mellifera bee on Staphylococcus aureus strains
- 1 April 2020
- Published by Elsevier in Microbial Pathogenesis
- Vol. 141, 104011
Influence of apitoxin and melittin from Apis mellifera bee on Staphylococcus aureus strains
- 1 January 2019
- Published by Elsevier in Microbial Pathogenesis
- Vol. 126, 231-238
Antibacterial and anti-biofilm activities of cinnamaldehyde against S. epidermidis
- 1 January 2019
- Published by Elsevier in Microbial Pathogenesis
- Vol. 126, 231-238
Antibacterial and anti-biofilm activities of cinnamaldehyde against S. epidermidis